Effect of hemorheological parameters on myocardial injury after primary or elective percutaneous coronary intervention

被引:8
作者
Fracassi, Francesco [1 ]
Vetrugno, Vincenzo [1 ]
Mandurino-Mirizzi, Alessandro [1 ]
Cosentino, Nicola [1 ]
Panicale, Serena [2 ]
Caprari, Patrizia [2 ]
Niccoli, Giampaolo [1 ]
Crea, Filippo [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Cardiol, Largo Francesco Vito 8, I-00168 Rome, Italy
[2] Italian Natl Inst Hlth, Rome, Italy
关键词
blood viscosity; coronary angioplasty; hemorheology; microvascular obstruction; periprocedural necrosis; WHOLE-BLOOD VISCOSITY; ST-SEGMENT ELEVATION; SLOW-FLOW; INFARCTION; AGGREGATION; REPERFUSION; RISK; DYSFUNCTION; GUIDELINES; PLASMA;
D O I
10.1097/MCA.0000000000000661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAbnormal blood viscosity favors atherosclerosis owing to endothelial dysfunction and changes in shear stress. Its effect on coronary microvasculature during percutaneous coronary intervention (PCI) is still unknown. We aimed to investigate the role of hemorheological parameters in the incidence of microvascular obstruction (MVO) and the periprocedural necrosis after primary or elective PCI, and secondarily, we evaluated their prognostic significance.Materials and methodsWe enrolled 25 patients with ST-elevation myocardial infarction (STEMI), 30 patients with non-ST-elevation myocardial infarction (NSTEMI), and 30 patients with stable angina (SA) undergoing PCI. MVO in patients with STEMI and periprocedural necrosis in patients with NSTEMI and those with SA were assessed using angiographic/electrocardiographic and laboratory methods, respectively. Hemorheological profile included blood viscosity () at shear rates 200s(-1) and 1s(-1), the erythrocyte aggregation index ((1)/(200)), and plasma viscosity. Major adverse cardiovascular events occurrence was evaluated at follow-up.ResultsPatients with STEMI experiencing angiographic MVO (28%) had higher (200) (5.421.28 vs. 3.98 +/- 1.22mPa.s; P=0.015). Similarly, patients with STEMI experiencing electrocardiographic MVO (56%) had higher (200) (4.58 +/- 0.36 vs. 3.94 +/- 0.19mPa.s; P<0.001). Among patients with SA and patients with NSTEMI, those experiencing periprocedural necrosis (23.3%) had higher (200) (5.30 +/- 0.86 vs. 4.37 +/- 0.88mPa.s; P=0.001), (1) (19.52 +/- 9.62 vs. 13.29 +/- 7.65mPa.s; P=0.015) and (1)/(200) values (3.64 +/- 1.50 vs. 2.72 +/- 0.92; P=0.007). These significant differences were maintained after adjustment for age, sex, and cardiovascular risk factors. At follow-up (30 +/- 6 months), 25 (29.4%) patients presented major adverse cardiovascular events, and they had higher (200) (5.18 +/- 1.00 vs. 4.25 +/- 1.01mPa.s; P<0.001).ConclusionIn patients undergoing either urgent or elective PCI, hemorheological parameters might contribute to myocardial injury and, if furtherly confirmed, to an unfavorable outcome.
引用
收藏
页码:638 / 646
页数:9
相关论文
共 50 条
  • [21] The role of myocardial work in evaluating coronary microcirculation of STEMI patients after percutaneous coronary intervention
    Liu Ruizhong
    Liu Yanhong
    Wang Fei
    Wu Yushi
    Lai Yuqiong
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2021, 38 (12): : 2060 - 2068
  • [22] Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury
    Balian, Vruyr
    Galli, Michele
    Marcassa, Claudio
    Cecchin, Gianni
    Child, Maurice
    Barlocco, Fabio
    Petrucci, Ettore
    Filippini, Giulia
    Michi, Riccardo
    Onofri, Marco
    CIRCULATION, 2006, 114 (18) : 1948 - 1954
  • [23] Elective Percutaneous Coronary Intervention The Relationship between Preprocedural Blood Glucose Levels and Periprocedural Myocardial Injury
    Madani, Mohsen
    Alizadeh, Keivan
    Ghazaee, Sepideh Parchami
    Zavarehee, Abbas
    Abdi, Seifollah
    Shakerian, Farshad
    Salehi, Negar
    Firouzi, Ata
    TEXAS HEART INSTITUTE JOURNAL, 2013, 40 (04): : 410 - 417
  • [24] Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
    Zhou, You
    Chen, Zhangwei
    Ma, Jiaqi
    Chen, Ao
    Lu, Danbo
    Wu, Yuan
    Ren, Daoyuan
    Zhang, Chi
    Dai, Chunfeng
    Zhang, Yaqi
    Qian, Juying
    Ge, Junbo
    JOURNAL OF CARDIOLOGY, 2020, 76 (03) : 309 - 316
  • [25] Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial)
    Gorter, Thomas M.
    Lexis, Chris P. H.
    Hummel, Yoran M.
    Lipsic, Erik
    Nijveldt, Robin
    Willems, Tineke P.
    van der Horst, Iwan C. C.
    van der Harst, Pim
    van Melle, Joost P.
    van Veldhuisen, Dirk J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (03) : 338 - 344
  • [26] Curcumin for the prevention of myocardial injury following elective percutaneous coronary intervention; a pilot randomized clinical trial
    Aslanabadi, Naser
    Entezari-Maleki, Taher
    Rezaee, Haleh
    Jafarzadeh, Hamed Reza
    Vahedpour, Reza
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 858
  • [27] Right ventricular myocardial infarction in the era of primary percutaneous coronary intervention
    Koc, L.
    Ondrus, T.
    Fila, P.
    Richter, S.
    Kala, P.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2021, 122 (10): : 700 - 707
  • [28] Quantitative Assessment of Myocardial Perfusion Using Time-Density Curve Analysis After Elective Percutaneous Coronary Intervention
    Esposito, Michele
    Shah, Nimish N.
    Korabathina, Ravikiran
    Pan, Chris
    Paruchuri, Vikram
    Finley, John
    Shah, Ameer
    Boyle, Andrew
    Vaillant, Regis
    Kimmelstiel, Carey D.
    Kapur, Navin K.
    JOURNAL OF INVASIVE CARDIOLOGY, 2014, 26 (02) : 60 - 63
  • [29] The Challenge of Microvascular Obstruction After Primary Percutaneous Coronary Intervention
    Niccoli, Giampaolo
    CURRENT VASCULAR PHARMACOLOGY, 2013, 11 (02) : 243 - 244
  • [30] Impact of metabolic syndrome on myocardial injury and clinical outcome after percutaneous coronary intervention
    Li, J.
    Song, S. -J.
    Xu, J. -P.
    Zhao, X. -Z.
    Xu, Z. -W.
    Sun, X. -J.
    Wang, L. -F.
    Yang, X. -C.
    HERZ, 2015, 40 (01) : 129 - 135